Musely: Setting the Standard in Telemedicine
Musely, the innovative telemedicine company, has recently achieved a remarkable milestone by being named the #1 Best Online Platform in the Health Care category by Newsweek in their America's Best Online Platforms 2026. This accolade recognizes Musely's unwavering commitment to enhancing patient care through technology and underscores its impressive growth in a competitive landscape.
Founded in 2019, Musely has transformed how individuals access healthcare services, serving more than 1.3 million patients across the nation. With a robust score of 9.07, it stands out as the only platform in its category to break the 9.0 barrier, a testament to its superior quality and patient satisfaction.
A Rigorous Evaluation Process
The ranking was part of a comprehensive evaluation that encompassed over 20,000 online platforms across various industries, with only 500 making the final list. Musely was evaluated based on several key performance indicators, including impression, usage, trust, mobile usability, traffic growth, and technical performance. This extensive analysis was conducted independently in partnership with Statista, ensuring that the results were unbiased and reflective of real consumer experiences.
Jennifer H. Cunningham, Newsweek’s Editor-in-Chief, emphasized the importance of these rankings in guiding users towards reliable and secure digital platforms. The meticulous approach taken in this evaluation process not only highlights Musely's excellence but also the importance of transparency in online healthcare services.
The Vision of Accessibility
At the heart of Musely’s innovation is a vision of making expert prescription care conveniently accessible to every individual. According to Jack Jia, the Founder and CEO of Musely, the goal has always been to provide healthcare that rivals the best technology products available today. This vision materializes through Musely’s range of services which includes personalized treatments in dermatology, hair restoration, hormone replacement therapy (HRT), and longevity, allowing patients to receive care from the comfort of their homes.
Recognition and Growth
This recent recognition follows another significant achievement for Musely earlier this year, where it was also listed among USA Today’s Most Trusted Brands in the Beauty and Health category, ranking #7. Musely stood alongside renowned brands such as Neutrogena and Dove, further enhancing its reputation as a trusted provider in telemedicine.
In addition to awards, Musely has successfully secured over $360 million in non-dilutive growth capital from General Catalyst’s Customer Value Fund, enabling it to expand its reach and services while maintaining founder-led operations. This substantial investment underscores the confidence investors have in Musely's future in digital health.
Conclusion: The Future of Healthcare
With a growing demand for technology-driven healthcare solutions, Musely is poised to redefine how individuals perceive and interact with their health providers. As it continues on this trajectory of growth and innovation, the company remains committed to helping people look good, feel better, and live healthier lives.
For more information about Musely and its services, visit
www.musely.com.